WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

Phase 1

Completed

Conditions: Triple Negative Breast Cancer
Triple-Negative Breast Cancer
Triple Negative Breast Neoplasms

Interventions: Biological: Personalized polyepitope DNA vaccine

First Posted Date: 2015-01-28

Last Posted Date: 2020-07-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 18

Registration Number: NCT02348320

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)

Phase 1

Terminated

Conditions: Non-Small Cell Lung Cancer
Nonsmall Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Pacritinib
Drug: Erlotinib

First Posted Date: 2015-01-19

Last Posted Date: 2018-02-27

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT02342353

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Treatment -Resistant Neovascular Age-Related Macular Degeneration

Phase 1

Completed

Conditions: Macular Degeneration

Interventions: Drug: Rituximab

First Posted Date: 2015-01-07

Last Posted Date: 2015-06-03

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 5

Registration Number: NCT02332941

Locations: 🇺🇸
Washington University School of Medicine, St Louis, Missouri, United States

Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device

Phase 1

Terminated

Conditions: Cancer
Malignant Tumor

Interventions: Device: Magnetic resonance imaging

First Posted Date: 2015-01-06

Last Posted Date: 2017-02-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT02331381

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Phase 1

Terminated

Conditions: Uterine Cervical Cancer
Uterine Cervical Neoplasms
Cervical Cancer

Interventions: Device: FDG-PET/MR
Device: FDG-PET/CT

First Posted Date: 2014-12-16

Last Posted Date: 2020-06-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT02317302

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

Early Phase 1

Completed

Conditions: Melanoma
Breast Cancer
Cancer of Breast
Cancer of the Breast
Malignant Melanoma

Interventions: Procedure: Sentinel lymph node biopsy
Device: Goggle-based device with light-emitting diodes (LED)
Drug: Indocynanine Green

First Posted Date: 2014-12-15

Last Posted Date: 2019-09-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT02316795

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Cap Assisted Balloon Enteroscopy Versus Conventional Balloon Enteroscopy In The Evaluation Of Obscure Gastrointestinal Bleeding: A Randomized Controlled Trial

Not Applicable

Terminated

Conditions: Obscure Gastrointestinal Bleeding

Interventions: Procedure: CAP

First Posted Date: 2014-12-11

Last Posted Date: 2018-06-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 87

Registration Number: NCT02315404

Locations: 🇺🇸
Washington University in St Louis, Saint Louis, Missouri, United States

FMT for Multidrug Resistant Organism Reversal

Phase 1

Completed

Conditions: Infection With Multi-drug Resistant Organisms

Interventions: Biological: Fecal microbiota transplantation (FMT)

First Posted Date: 2014-12-09

Last Posted Date: 2021-02-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1

Registration Number: NCT02312986

MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas

Phase 1

Completed

Conditions: Malignant Glioma

Interventions: Biological: MK-3475
Device: MRI-guided laser ablation
Procedure: Surgical resection/debulking
Procedure: Blood draw for research purposes
Procedure: Biopsy
Procedure: Cervical lymph node fine needle aspiration

First Posted Date: 2014-12-08

Last Posted Date: 2024-05-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 55

Registration Number: NCT02311582

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

Phase 1

Completed

Conditions: Brain Metastases

Interventions: Device: dynamic susceptibility-weighted contrast-enhanced perfusion magnetic resonance imaging

First Posted Date: 2014-12-08

Last Posted Date: 2017-02-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 23

Registration Number: NCT02311556

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy